Lower Cumulative Incidence of Relapse but Higher Incidence of NRM in Patients with Poor Graft Function Following Allogeneic Stem Cell Transplantation

被引:0
|
作者
Prabahran, Ashvind [1 ,2 ,3 ,4 ]
Koldej, Rachel [1 ,2 ]
Chee, Lynette C. Y. [1 ,2 ,4 ,5 ]
Ritchie, David S. [1 ,2 ,4 ,5 ]
机构
[1] Royal Melbourne Hosp, ACRF Lab, Parkville, Vic, Australia
[2] Univ Melbourne, Dept Med, Parkville, Vic, Australia
[3] Peter MacCallum Canc Ctr, Dept Clin Haematol & Bone Marrow Transplantat, Melbourne, Australia
[4] Royal Melbourne Hosp, Melbourne, Vic, Australia
[5] Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Vic, Australia
关键词
D O I
10.1182/blood-2023-190941
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation
    DR Simpson
    TJ Nevill
    JD Shepherd
    HC Fung
    DE Horsman
    SH Nantel
    LM Vickars
    HJ Sutherland
    CL Toze
    DE Hogge
    HG Klingemann
    SC Naiman
    MJ Barnett
    Bone Marrow Transplantation, 1998, 22 : 259 - 264
  • [42] Association of tacrolimus concentrations with incidence of acute graft-versus-host disease and relapse after matched allogeneic hematopoetic stem cell transplantation in adult patients
    Moiseev, I.
    Senina, N.
    Vavilov, V.
    Slesarchuk, O.
    Bondarenko, S.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S180 - S180
  • [43] Incidence and outcome of posterior reversible encephalopathy syndrome in paediatric patients following allogeneic haematopoietic stem cell transplantation
    Hussein, A. A.
    Mansour, A.
    Kamona, A.
    Rihani, R.
    Abdul-Rahman, F.
    Ensirat, T.
    Hussain, A. H.
    Sarhan, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S84 - S84
  • [44] Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function
    Davulcu, Eren Arslan
    Soyer, Nur Akad
    Vural, Filiz
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [45] Use of Eltrombopag in Improving Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
    Master, Samip
    Dwary, Ashish
    Mansour, Richard
    Mills, Glenn M.
    Koshy, Nebu
    CASE REPORTS IN ONCOLOGY, 2018, 11 (01): : 191 - 195
  • [46] Poor graft function, a significant and emerging clinical challenge post allogeneic stem cell transplantation
    Prabahran, Ashvind A.
    Ritchie, David S.
    LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 2786 - 2787
  • [47] Clinical Characteristics and Frequency of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation
    Sahin, U.
    Yuksel, M. Kurt
    Merter, M.
    Gunduz, M.
    Ozdemir, Z. Narli
    Bozdag, S. Civriz
    Toprak, S. K.
    Topcuoglu, P.
    Arslan, O.
    Ozcan, M.
    Demirer, T.
    Ilhan, O.
    Akan, H.
    Beksac, M.
    Gurman, G.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S450 - S450
  • [48] Patients with Lower Clearance of Busulfan Have Higher Risk of Graft Loss When Undergoing Allogeneic Stem Cell Transplantation
    Al Khabori, Murtadha
    Al Lawati, Bushra M.
    Al Zaabi, Mohamed
    Al Huneini, Mohammed
    Dennison, David
    Al Rawas, Abdulhakeem
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S301 - S301
  • [49] Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation
    Al-Ramahi, Joe S.
    Shahzad, Moazzam
    Nguyen, Andrea
    Li, Kevin
    Amin, Muhammad Kashif
    Ahmed, Nausheen
    Lutfi, Forat
    Dejarnette, Shaun
    Chaudhary, Sibgha Gull
    Bansal, Rajat
    Abdelhakim, Haitham
    Shune, Leyla
    Abdallah, Al-Ola
    Singh, Anurag K.
    Abhyankar, Sunil H.
    Mcguirk, Joseph P.
    Mushtaq, Muhammad Umair
    BONE MARROW TRANSPLANTATION, 2024, 59 (01) : 134 - 137